Electronic Cigarettes and Female Reproduction: A Systematic Review of Experimental and Clinical Evidence
Abstract
Electronic cigarettes (e-cigarettes) have gained widespread diffusion as a perceived safer alternative to conventional smoking, particularly among women of reproductive age. The present systematic review provides an overview of the current literature on the effects of e-cigarette exposure on female reproductive function, embryonic development, and pregnancy outcomes, with a focus on underlying molecular mechanisms. A systematic literature search was conducted in PubMed, Web of Science, and Google Scholar, and the review was conducted in accordance with the PRISMA 2020 guidelines. A total of 11 studies met the eligibility criteria and were included in the qualitative synthesis, comprising six experimental and five clinical studies. Experimental studies suggest that e-cigarette exposure may impair ovarian function, leading to morphological alterations, disrupted folliculogenesis, and altered steroidogenesis, mainly through oxidative stress, apoptosis, mitochondrial dysfunction, and dysregulation of pathways such as Hippo signaling. Non-nicotine components, including propylene glycol (PG), vegetable glycerin (VG), and flavoring agents, appear to be key contributors. Adverse effects on implantation, embryo development, and placental growth have also been reported in experimental models, although further studies are needed. Clinical evidence remains scarce, suggesting possible associations between e-cigarette smoking and reduced ovarian reserve and fecundability in naturally…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.